PARI LC SPRINT® XLent Nebuliser

Users
For children and adults for the treatment of throat and pharynx.

PARI LC SPRINT XLent Nebulisers are compatible for use with PARI BOY, PARI COMPACT N and PARI SINUS N devices.

  • PARI LC SPRINT XLent Nebuliser (transparent nozzle attachment)
  • Connection tubing
  • Tubing adapter for use with PARI COMPACT N

Blue nozzle attachment
The blue nozzle attachment delivers droplets for efficient deposition in the central region of the lungs in older children and adults. 
The blue nozzle can be found in the PARI LC SPRINT Nebuliser.

Yellow nozzle attachment
The yellow nozzle attachment delivers an especially fine aerosol for the small airways and for the treatment of babies and children.
The yellow nozzle can be found in the PARI LC SPRINT Junior Nebuliser.

Red nozzle attachment
Extra-fine droplets specifically for babies and young children in the obstructive phase – supplied, for instance, with the PARI JuniorBOY. The red nozzle attachment is also supplied with the PARI BOY to reach the finest structures of the lungs, specifically for COPD patients.
The red nozzle can be found in the: PARI LC SPRINT BABY Nebuliser and PARI LC SPRINT STAR Nebuliser.

Transparent nozzle attachment
To ensure active substances are optimally delivered to the upper airways, such as the throat, larynx and the trachea, extra large aerosol droplets are needed. The PARI XLent nozzle attachment generates these “XL droplets” and produces an ideal aerosol spectrum for the treatment of croup, pharyngitis or laryngitis, for instance.
The transparent nozzle can be found in the: PARI LC SPRINT XLent Nebuliser

Orange nozzle attachment
In combination with a pulsing feature, the orange nozzle attachment delivers an ideal aerosol spectrum for efficient deposition in the sinuses.
The orange nozzle can be found in the: PARI LC SPRINT SINUS Nebuliser

PARI LC SPRINT XLent Nebuliser in combination with PARI BOY Compressor.

Respirable Drug Delivery Rate:n.a.
MMAD:6.6 µm
Mass fraction > 5 µm:62 %

Measurement according to DIN EN ISO 27427:2020-2 (with salbutamol.)

Item No.: 023G1805